Assessment of Serum Thrombomodulin in Patients with Systemic Lupus Erythematosus in Rheumatology Research Center

Assessment of Serum Thrombomodulin in Patients with Systemic Lupus Erythematosus in Rheumatology Research Center

At present, some clinical presentations and serological parameters such as products of complement activation and elevation of autoantibodies (e.g. dsDNA antibodies), erythrocyte sedimentation rate (ESR), levels of C-reactive protein (CRP), or cytokines such as IL-2/IL-2 receptor, IL-6 and IL-10 are...

Full description

Bibliographic Details
Main Authors:	Mahmood Akbarian, Farhad Gharibdoost, Mehrzad Hadjaliloo, Abdolhadi Nadji, Ahmad Reza Jamshidi, Farhad Shahram, Masoomeh Akhlaghi, Shahrzad Khosravi, Simin Almasi, Fereydoun Davatchi
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2009-04-01
Series:	Acta Medica Iranica
Subjects:	Systemic Lupus Erythematosus Thrombomodulin SLE disease Activity
Online Access:	https://acta.tums.ac.ir/index.php/acta/article/view/3554

Similar Items

Isolated Hematuria in SLE Patients and its Association with Proteinuria, Uri-nary Cast and SLE Disease Activity
by: Mahmood Akbarian, et al.
Published: (2009-02-01)

Isolated Hematuria in SLE Patients and its Association with Proteinuria, Uri-nary Cast and SLE Disease Activity
by: Akbarian M, et al.
Published: (2009-04-01)

CONVULSION AND ITS RELATION TO ANTI-DNA ANTIBODY LEVELS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: F. Gharibdoost, et al.
Published: (1999-07-01)

The epidemiology of systemic lupus erythematosus in Iran: a survey on 2143 cases
by: Akbarian M, et al.
Published: (2010-08-01)

Evaluation of the mortality in systemic Lupus erythematosis (SLE): Analysis of 2021 patients
by: Gharibdoost F, et al.
Published: (2003-03-01)

The role of thrombomodulin lectin-like domain in inflammation
by: Li Yi-Heng, et al.
Published: (2012-03-01)

Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures
by: Mallorie Boron, et al.
Published: (2022-07-01)

Increased thrombomodulin level in hypertensive disorders of pregnancy
by: Zainab Abdul Abbas Hashim, et al.
Published: (2022-01-01)

Chondrocyte Thrombomodulin Protects against Osteoarthritis
by: Lin Kang, et al.
Published: (2023-05-01)

Effect of dengue hemorrhagic fever on thrombomodulin level
by: Hendra Widjaja, et al.
Published: (2009-10-01)

Recombinant Thrombomodulin Suppresses Histone-Induced Neutrophil Extracellular Trap Formation
by: Binita Shrestha, et al.
Published: (2019-10-01)

Value of Serum Thrombomodulin as a Marker and Predictor in Patients with Sepsis-Associated Acute Kidney Injury
by: Nguyen VT, et al.
Published: (2023-07-01)

Plasma thrombomodulin as a candidate biomarker for the diagnosis and prognosis of HBV-related acute-on-chronic liver failure
by: Zhou X, et al.
Published: (2024-03-01)

Coagulofibrinolytic effects of recombinant soluble thrombomodulin in prolonged porcine cardiac arrest
by: Boya Zhang, et al.
Published: (2023-12-01)

The relation of thrombomodulin G33A and C1418T gene polymorphisms to the risk of acute myocardial infarction in Egyptians
by: Wael Alkhiary, et al.
Published: (2018-01-01)

Migraine In Systemic Lupus Erythematosus in Rheumatological outpatients unit
by: Ameer Shaker
Published: (2019-11-01)

Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis
by: Takaaki Totoki, et al.
Published: (2024-01-01)

Thrombomodulin Serum Levels—A Predictable Biomarker for the Acute Onset of Ischemic Stroke
by: Andrei-Lucian Zaharia, et al.
Published: (2024-01-01)

Protective Role of Recombinant Human Thrombomodulin in Diabetes Mellitus
by: Yuko Okano, et al.
Published: (2021-08-01)

Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin
by: Hideo Wada, et al.
Published: (2023-01-01)

Thrombomodulin expression impacts the recurrence and long‐term survival in pancreatic cancer
by: Hiroshi Sugano, et al.
Published: (2021-07-01)

Comparison of thrombomodulin, vWF, and ADAMTS13 levels between preeclampsia and normal pregnancy
by: Aisha Ahmad, et al.
Published: (2023-12-01)

The Role of Thrombomodulin in Estrogen-Receptor-Positive Breast Cancer Progression, Metastasis, and Curcumin Sensitivity
by: Chien-Yu Huang, et al.
Published: (2023-05-01)

Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Takuma Isshiki, et al.
Published: (2019-05-01)

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2017-11-01)

Effects of recombinant human soluble thrombomodulin on neutrophil extracellular traps in the kidney of a mouse model of endotoxin shock
by: Tatsuhiko Harada, et al.
Published: (2023-08-01)

Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study
by: Takahiro Kato, et al.
Published: (2018-08-01)

Endotheliopathy, Soluble Thrombomodulin and Its Role in Predicting Prognosis in Severe Coronavirus Disease-2019 Pneumonia
by: Hanife Usta Atmaca, et al.
Published: (2023-08-01)

Absence of the lectin-like domain of thrombomodulin reduces HSV-1 lethality of mice with increased microglia responses
by: Meng-Shan Tsai, et al.
Published: (2022-03-01)

Thrombomodulin and interleukin 6 as potential biomarkers of endothelial dysfunction and inflammation after renal transplant
by: Ana Paula L. Mota, et al.
Published: (2018-12-01)

Thrombomodulin activation driven by LXR agonist attenuates renal injury in diabetic nephropathy
by: Wei Wang, et al.
Published: (2023-01-01)

CLINICAL AND LABORATORY MANIFESTATIONS OF THROMBOCYTOPENIA IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: I. Salehi., et al.
Published: (1997-06-01)

CLINICAL AND LABORATORY MANIFESTATIONS OF THROMBOCYTOPENIA IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: I. Salehi., et al.
Published: (1997-06-01)

Recombinant Human Soluble Thrombomodulin Suppresses Monocyte Adhesion by Reducing Lipopolysaccharide-Induced Endothelial Cellular Stiffening
by: Takayuki Okamoto, et al.
Published: (2020-07-01)

Recombinant thrombomodulin may protect cardiac capillary endothelial glycocalyx through promoting Glypican-1 expression under experimental endotoxemia
by: Yoshinori Kakino, et al.
Published: (2022-11-01)

Prognostic factors in patients with septic disseminated intravascular coagulation treated with thrombomodulin: the effect of reduced thrombomodulin dose; a single-center, retrospective, observational study
by: Yoshihiro Nishita, et al.
Published: (2022-12-01)

Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation—A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients
by: Michael Hultström, et al.
Published: (2022-06-01)

Effects of thrombomodulin alfa on hemostatic parameters in disseminated intravascular coagulation: Post hoc analysis of a phase 3 randomized controlled trial
by: Takashi Ito, et al.
Published: (2020-10-01)

Web-based application for predicting the potential target phenotype for recombinant human thrombomodulin therapy in patients with sepsis: analysis of three multicentre registries
by: Tadahiro Goto, et al.
Published: (2022-05-01)

The chondroitin sulfate moiety mediates thrombomodulin-enhanced adhesion and migration of vascular smooth muscle cells
by: Vincent Chunpeng Pai, et al.
Published: (2018-02-01)